immunoGlobe GmbH成立于1997年，主要业务包括：1）生产研究用蛋白（特别关注信号转导及细胞骨架）；2）对学术机构提供的优良抗体进行商业化；3）提供定制的多克隆抗体生产和纯化。

Our Mission is to supply the Scientific Community with affordable high quality research antibodies and reagents. Towards this goal we are pursuing three major fields, since 1997:

Manufacturing of novel research antibodies (with a focus on signal transduction and the cytoskeleton). More than 50% of the still limited but constantly expanding product portfolio are unique research antibodies available from no other commercial source.

Commercialization of well characterized and established antibodies developed and licensed by our university partners. immunoGlobe® takes over packing, documentation, marketing, and distribution of the products. The company especially benefits also from the marketing activities of its world-wide distributors.

Production & affinity purification of polyclonal custom antibodies (antibody services). imunoGlobe has been one of the first service providers to offer fractional affinity purification with multiple columns! Based on sophisticated purification strategies, our special focus is on the generation of antibodies directed against modifications.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Schircks Laboratories品牌。

瑞士Schircks Laboratories由B.Schircks博士于1980年创立，主要生产蝶啶及蝶啶类化合物（Pteridines）。至今，Schircks实验室合成了100多种蝶啶类化合物，主要用于科学研究和临床诊断应用。产品包括：

艾美捷科技代理Nexcelom品牌。

2003年，Nexcelom的创始人推出了CP2，这是一种辅助手动细胞计数的方便工具。Nexcelom的创始人兼首席技术官JeanQiu博士说，“NIH的某位客户曾要求我们‘消除显微镜计数’。

为此，我们发明了CellometerAutoT4，用于测量细胞浓度和活力。”自那时起，Nexcelom扩大了产品范围，升级了系统功能，并优化了适用的方法，使研究人员能够分析所有细胞类型，

包括小细胞和原代细胞。凭借先进的专有技术，Nexcelom是细胞分析中基于图像的细胞计数的领导者和创新者。世界各地的科学家在学术和政府研究机构、生物技术和工业环境中使用

Cellometer，Cellaca和Celigo仪器进行细胞定量、分析和基于细胞的检测。Nexcelom图像细胞术和细胞分析解决方案被集成到生命科学的广泛工作流程中。